Compared to Estimates, RenaissanceRe (RNR) Q1 Earnings: A Look at Key Metrics

Zacks Zacks
Abrir en Zacks
Compared to Estimates, RenaissanceRe (RNR) Q1 Earnings: A Look at Key Metrics

For the quarter ended March 2026, RenaissanceRe (RNR) reported revenue of $2.61 billion, down 16.7% over the same period last year. EPS came in at $13.75, compared to -$1.49 in the year-ago quarter.

The reported revenue represents a surprise of -10.58% over the Zacks Consensus Estimate of $2.91 billion. With the consensus EPS estimate being $11.07, the EPS surprise was +24.23%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how RenaissanceRe performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Combined Ratio: 73% versus 82.7% estimated by three analysts on average. Combined Ratio - Property: 34.1% compared to the 54.1% average estimate based on three analysts. Combined Ratio - Casualty and Specialty: 100.4% versus the three-analyst average estimate of 101.9%. Net Claims and Claim Expense Ratio - calendar year: 45.1% versus 52.3% estimated by three analysts on average. Underwriting Expense Ratio - Casualty and Specialty: 30.3% versus the three-analyst average estimate of 33.5%. Net Claims and Claim Expense Ratio - calendar year - Casualty and Specialty: 70.1% compared to the 68.3% average estimate based on three analysts. Underwriting Expense Ratio: 27.9% versus 29.9% estimated by three analysts on average. Net premiums earned- Casualty and Specialty: $1.28 billion compared to the $1.45 billion average estimate based on three analysts. The reported number represents a change of -12.9% year over year. Revenues- Net investment income: $420.5 million compared to the $446.59 million average estimate based on three analysts. The reported number represents a change of +3.7% year over year. Net premiums earned- Property: $900.74 million versus the three-analyst average estimate of $1.01 billion. The reported number represents a year-over-year change of -27.8%. Revenues- Equity in earnings (losses) of other ventures: $20.49 million versus $10.25 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +14.9% change. Revenues- Net premiums earned: $2.18 billion compared to the $2.46 billion average estimate based on three analysts. The reported number represents a change of -19.7% year over year.

View all Key Company Metrics for RenaissanceRe here>>>

Shares of RenaissanceRe have returned +5.2% over the past month versus the Zacks S&P 500 composite's +12.8% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Zacks' Research Chief Names "Stock Most Likely to Double"

Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.

This top pick is a little-known satellite-based communications firm. Space is projected to become a trillion dollar industry, and this company's customer base is growing fast. Analysts have forecasted a major revenue breakout in 2025. Of course, all our elite picks aren't winners but this one could far surpass earlier Zacks' Stocks Set to Double like Hims & Hers Health, which shot up +209%.

Free: See Our Top Stock And 4 Runners Up

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
RenaissanceRe Holdings Ltd. (RNR): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research